©The Author(s) 2025.
World J Gastroenterol. Oct 28, 2025; 31(40): 111307
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111307
Published online Oct 28, 2025. doi: 10.3748/wjg.v31.i40.111307
Figure 1 Growth differentiation factor 11 induces Smad signaling pathway activation in THP-1-derived M0 macrophages.
A: Representative images of western blots; B-D: Densitometry analysis (β-actin was used as a loading control); E: Cell viability (H2O2 was used as a negative control); F: Cell proliferation (cytarabine was used as a negative control); G: Cellular morphology, each image is representative of at least three independent experiments. Scale bars: 150 μm (200 ×, original magnification). Each column or point represents the mean ± SEM of at least three independent experiments carried out in triplicate. aP ≤ 0.05 vs not treated cells. GDF11: Growth differentiation factor 11; NT: Not treated cells; AraC: Cytarabine.
- Citation: Escobedo-Calvario A, Chávez-Rodríguez L, Souza-Arroyo V, Bucio-Ortiz L, Miranda-Labra RU, Masso F, Páez-Arenas A, Hernández-Pando R, Marquardt J, Gutiérrez-Ruiz MC, Gomez-Quiroz LE. Growth differentiation factor 11 modulates metabolism, mitigating the pro-tumoral behavior provided by M2-like macrophages in hepatocellular carcinoma-derived cells. World J Gastroenterol 2025; 31(40): 111307
- URL: https://www.wjgnet.com/1007-9327/full/v31/i40/111307.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i40.111307